Search Results - Teresa Macarulla

Refine Results
  1. 1
    Ramucirumab in metastatic colorectal cancer: evidence to date and place in therapy

    Ramucirumab in metastatic colorectal cancer: evidence to date and place in therapy by Helena Verdaguer, Josep Tabernero, Teresa Macarulla

    Published 2016
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Novel targeted therapies in the treatment of gastric and esophageal cancer

    Novel targeted therapies in the treatment of gastric and esophageal cancer by Josep Tabernero, Teresa Macarulla, Francisco Javier Ramos, José Baselga

    Published 2005
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Tumor Treating Fields (TTFields) Therapy Concomitant with Taxanes for Cancer Treatment

    Tumor Treating Fields (TTFields) Therapy Concomitant with Taxanes for Cancer Treatment by Ignace Vergote, Teresa Macarulla, Fred R. Hirsch, Carsten Hagemann, David S. Miller

    Published 2023
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    First-line and second-line treatment of patients with metastatic pancreatic adenocarcinoma in routine clinical practice across Europe: a retrospective, observational chart review study

    First-line and second-line treatment of patients with metastatic pancreatic adenocarcinoma in routine clinical practice across Europe: a retrospective, observational chart review s... by Julien Taı̈eb, G. Prager, Davide Melisi, C. Benedikt Westphalen, Nathalie D’Esquermes, Anabel Ferreras, Alfredo Carrato, Teresa Macarulla

    Published 2020
    Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    IMbrave 151: a randomized phase II trial of atezolizumab combined with bevacizumab and chemotherapy in patients with advanced biliary tract cancer

    IMbrave 151: a randomized phase II trial of atezolizumab combined with bevacizumab and chemotherapy in patients with advanced biliary tract cancer by Stephen P. Hack, Wendy Verret, Sohail Mulla, Bo Liu, Yulei Wang, Teresa Macarulla, Zhenggang Ren, Anthony B. El-Khoueiry, Andrew X. Zhu

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Optimizing the management of locally advanced pancreatic cancer with a focus on induction chemotherapy: Expert opinion based on a review of current evidence

    Optimizing the management of locally advanced pancreatic cancer with a focus on induction chemotherapy: Expert opinion based on a review of current evidence by Thomas Seufferlein, Pascal Hammel, Jean‐Robert Delpéro, Teresa Macarulla, Per Pfeiffer, Gerald W. Prager, Michele Reni, Massimo Falconi, Philip A. Philip, Eric Van Cutsem

    Published 2019
    Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Efficacy and Safety of the MDM2–p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced Biliary Tract Cancer: A Case Series

    Efficacy and Safety of the MDM2–p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced Biliary Tract Cancer: A Case Series by Noboru Yamamoto, Anthony W. Tolcher, Navid Hafez, Iwona Ługowska, Rodryg Ramlau, Teresa Macarulla, Junxian Geng, Jian Li, Michael Teufel, Angela Märten, Patricia LoRusso

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Biliary tract cancers: SEOM clinical guidelines

    Biliary tract cancers: SEOM clinical guidelines by Manuel Benavides, A. Antón, Javier Gállego, María Auxiliadora Gómez, Ana-María Jiménez-Gordo, Adelaida La Casta, Berta Laquente, Teresa Macarulla, J. R. Rodríguez-Mowbray, Joan Maurel

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Development of peripheral neuropathy and its association with survival during treatment with nab-paclitaxel plus gemcitabine for patients with metastatic adenocarcinoma of the pancreas: A subset analysis from a randomised phase III trial (MPACT)

    Development of peripheral neuropathy and its association with survival during treatment with nab-paclitaxel plus gemcitabine for patients with metastatic adenocarcinoma of the panc... by David Goldstein, Daniel D. Von Hoff, Malcolm J. Moore, Edward Greeno, Giampaolo Tortora, Ramesh K. Ramanathan, Teresa Macarulla, Helen Liu, Richard Pilot, Stefano Ferrara, Brian Lu

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Dose modification and efficacy of nab-paclitaxel plus gemcitabine vs. gemcitabine for patients with metastatic pancreatic cancer: phase III MPACT trial

    Dose modification and efficacy of nab-paclitaxel plus gemcitabine vs. gemcitabine for patients with metastatic pancreatic cancer: phase III MPACT trial by Werner Scheithauer, Ramesh K. Ramanathan, Malcolm J. Moore, Teresa Macarulla, David Goldstein, Pascal Hammel, Volker Kunzmann, Helen Liu, D. McGovern, Alfredo Romano, Daniel D. Von Hoff

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    RATIONALE 301 Study: Tislelizumab Versus Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma

    RATIONALE 301 Study: Tislelizumab Versus Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma by Shukui Qin, Richard S. Finn, Masatoshi Kudo, Tim Meyer, Arndt Vogel, Michel Ducreux, Teresa Macarulla, Gianluca Tomasello, Frédéric Boisserie, Jeannie Hou, Xin Li, James Song, Andrew X. Zhu

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    First-line liposomal irinotecan with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) in pancreatic ductal adenocarcinoma: A phase I/II study

    First-line liposomal irinotecan with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) in pancreatic ductal adenocarcinoma: A phase I/II study by Zev A. Wainberg, Tanios Bekaii‐Saab, Patrick M. Boland, Farshid Dayyani, Teresa Macarulla, Kabir Mody, Bruce Belanger, Fiona Maxwell, Yan Moore, Arunthathi Thiagalingam, Tiffany Wang, Bin Zhang, Andrew Dean

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Cetuximab administered once every second week to patients with metastatic colorectal cancer: a two-part pharmacokinetic/pharmacodynamic phase I dose-escalation study

    Cetuximab administered once every second week to patients with metastatic colorectal cancer: a two-part pharmacokinetic/pharmacodynamic phase I dose-escalation study by Josep Tabernero, Fortunato Ciardiello, Fernando Rivera, Edith Rodríguez-Braun, Francisco Javier Ramos, Erika Martinelli, M. E. Vega-Villegas, Susana Roselló, Stefan Liebscher, O. Kisker, Teresa Macarulla, José Baselga, Andrés Cervantes

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer

    Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer by Eric Van Cutsem, Manuel Hidalgo, Jean‐Luc Canon, Teresa Macarulla, I. Bazin, Elena Poddubskaya, Nebojša Manojlović, Dejan Radenković, Chris Verslype, Éric Raymond, Antonio Cubillo, Armin Schueler, Charles Zhao, Pascal Hammel

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    First-In-Human Phase I Study of Lurbinectedin (PM01183) in Patients with Advanced Solid Tumors

    First-In-Human Phase I Study of Lurbinectedin (PM01183) in Patients with Advanced Solid Tumors by María Elena Elez, Josep Tabernero, David Geary, Teresa Macarulla, Soonmo Peter Kang, Carmen Kahatt, Arturo Soto-Matos Pita, Carlos Fernández Teruel, Mariano Siguero, Martín Cullell-Young, Sergio Szyldergemajn, Mark J. Ratain

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

    Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treat... by Eric Van Cutsem, Josep Tabernero, Radek Lakomý, Hans Prenen, Jana Prausová, Teresa Macarulla, Paul Ruff, Guy A. Van Hazel, Vladimir Moiseyenko, David Ferry, Joe McKendrick, Jonathan Polikoff, Alexia Tellier, R Castan, Carmen J. Allegra

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Molecular Profiling of Patients with Colorectal Cancer and Matched Targeted Therapy in Phase I Clinical Trials

    Molecular Profiling of Patients with Colorectal Cancer and Matched Targeted Therapy in Phase I Clinical Trials by Rodrigo Dienstmann, Danila Serpico, Jordi Rodón, Cristina Saura, Teresa Macarulla, Elena Élez, María Alsina, Jaume Capdevila, José Manuel Pérez-García, Gessamí Sánchez-Ollé, Claudia Aura, Ludmila Prudkin, Stefania Landolfi, Javier Hernández‐Losa, Ana Vivancos, Josep Tabernero

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer

    Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer by Davide Melisi, Rocio García‐Carbonero, Teresa Macarulla, Denis Pezet, G. Deplanque, Martin Fuchs, Jörg Trojan, Helmut Oettle, Mark Kozloff, Ann Cleverly, Claire Smith, Shawn T. Estrem, Ivelina Gueorguieva, Michael Lahn, Al Blunt, Karim A. Benhadji, Josep Tabernero

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Geographic and Ethnic Heterogeneity of Germline <i>BRCA1</i> or <i>BRCA2</i> Mutation Prevalence Among Patients With Metastatic Pancreatic Cancer Screened for Entry Into the POLO Trial

    Geographic and Ethnic Heterogeneity of Germline <i>BRCA1</i> or <i>BRCA2</i> Mutation Prevalence Among Patients With Metastatic Pancreatic Cancer Screened for Entry Into the POLO T... by Talia Golan, Hedy L. Kindler, Joon Oh Park, Michele Reni, Teresa Macarulla, Pascal Hammel, Eric Van Cutsem, Dirk Arnold, Daniel Hochhauser, David McGuinness, Gershon Y. Locker, Teodora Goranova, Philipp Schatz, Yuzhen Liu, Michael J. Hall

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    ESMO Scale for Clinical Actionability of Molecular Targets Driving Targeted Treatment in Patients with Cholangiocarcinoma

    ESMO Scale for Clinical Actionability of Molecular Targets Driving Targeted Treatment in Patients with Cholangiocarcinoma by Helena Verdaguer, Tamara Saurí, Daniel Acosta, Magdalena Guardiola, Alexandre Sierra, Jorge Hernando, Paolo Nucíforo, Josep M. Miquel, Cristina Molero, Sandra Peiró, Queralt Serra-Camprubí, Guillermo Villacampa, Susana Aguilar, Ana Vivancos, Josep Tabernero, Rodrigo Dienstmann, Teresa Macarulla

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: